期刊文献+

VEGF在宫颈小细胞神经内分泌癌组织中表达及意义

Expression and Significance of VEGF in Small Cell Neuroendocrine Carcinoma of Cervix
下载PDF
导出
摘要 【目的】探讨血管内皮生长因子(VEGF)在宫颈小细胞神经内分泌癌组织(SCNC)中表达及意义。【方法】收集宫颈鳞癌(SCC)患者23例标本(SCC组)、SCNC患者23例标本(SCNC组)及正常宫颈23例标本(对照组),三组均采用免疫组织化学技术检测VEGF表达,并分析其表达与SCNC临床病理指标的相关性和生存时间。【结果】对照组、SCC组、SCNC组中 VGFR 的阳性率分别为0%、52.2%、82.6%,三组比较有统计学意义(P<0.05);VEGF高表达与 SCNC临床分期、病理亚型、肌层侵犯程度有关(P<0.05);VEGF表达阴性患者3年生存率75%显著高于表达阳性的3年生存率(15.8%),其差异有统计学意义(P <0.05)。【结论】VEGF高表达可能与 SCNC的强侵袭性生物学特点有关,可作为 SCNC的诊断及预后判断提供依据。 [Objective]To explore the expression and significance of VEGF in small cell neuroendocrine carcinoma of cervix(SCNC).[Methods]The specimens of 23 patients with squamous carcinoma of cervix (SCC)(group SCC),23 SCNC patients(group SCNS)and 23 patients with normal cervix(control group)were collected.Immunohistochemistry method was used to detect the expression of VEGF in 3 groups.The correla-tion between VEGF expression and clinical pathological indexes of SCNC and survival time were analyzed.[Re-sults]The positive expression rates of VEGF in control group,SCC group and SCNC group were 0%,52.2%and 82.6% respectively,and there was significant difference among 3 groups(P〈0.05).High expression of VEGF was correlated with clinical stage,pathological subtypes and muscular invasion(P〈0.05).The 3-year survival rate of patients with negative expression of VEGF was 75%,which was markedly higher than that of patients with positive expression of VEGF (15.8%),and there was significant difference (P 〈0.05 ).[Conclusion]High expression of VEGF may be associated with biological characteristics such as the strong in-vasion,and can provide the evidence for the diagnosis and prognosis of SCNC.
出处 《医学临床研究》 CAS 2014年第5期928-930,共3页 Journal of Clinical Research
关键词 宫颈肿瘤 病理学 血管内皮生长因子类 Uterine Cervical Neoplasms/PA Vascular Endothelial Growth Factors
  • 相关文献

参考文献7

  • 1金滢,蒋湘,李艳,黄惠芳,吴鸣,沈铿,潘凌亚.宫颈小细胞癌14例临床分析[J].基础医学与临床,2013,33(3):270-274. 被引量:9
  • 2Parenti A, Leo G, Porzionato A, et al . Expression of sur- vivin, p53, and caspase 3 in Barretfs esophagus carcinogenesis [J]. Hum Pathol, 2006, 37(1) : 16-22.
  • 3Giorgadze T,Kanhere R,Pang C, et al . Small cell carcinoma of the cervix in liquid-based Pap test: Utilization of spilt-sam- ple immunocytochemical and molecular analysis [J]. Diagn Cytopathol, 2012 ,40(3) :214-219.
  • 4AgarwalR, Whang DH, Alvero AB, e al. Macrophagemigra- tion inhibitory factor expression in ovarian cancer[J]. Am J Obstet Gynecol, 2007,196(4) : 348.
  • 5Law AB, Erridge SC, MacKean MJ, e al. Improving out- comes forlimited stage small cell lung cancer patients in Scot- land with concomitant chemoradiation[J]. J Clin Oncol (R Coll Radiol), 2007, 19(3) 188-193.
  • 6Huang CY, Chen YL, Chu TC, et al . Prognostic factors in women with early stage small cell carcinoma of the uterine cer- vix[J]. Oncol Res , 2009,18(56) : 279-286.
  • 7Wang KL, Yang YC, Wang TY, et al . Neuroendocrine carci- noma of the uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications [J]. J Chemother, 2006,18(2) : 209-216.

二级参考文献17

  • 1Crowder S,Tuller E. Small cell carcinoma of the female genital tract[J].Seminars in Oncology,2007.57-63.
  • 2Viswanathan AN,Deavers MT,Jhingran A. Small cell neuroendocrine carcinoma of the cervix:outcome and patterns of recurrence[J].Gynecologic Oncology,2004.27-33.
  • 3Pecorelli S,Zigliani L,Odicino F. Revised FIGO staging for carcinoma of the cervix[J].International Journal of Gynecology and Obstetrics,2009.107-108.
  • 4McCusker ME,Cot6 TR,Clegg LX. Endocrine tumors of the uterine cervix:incidence,demographics,and survival with comparison to squamous cell carcinoma[J].Gynecologic Oncology,2003.333-339.
  • 5Kasamatsu T,Sasajima Y,Onda T. Surgical treatment for neuroendocrine carcinoma of the cervix[J].International Journal of Gynecology and Obstetrics,2007.225-228.
  • 6Chan JK,Loizzi V,Burger RA. Prognostic factors in neuroendocrine small cell cervical carcinoma:a multivariate analysis[J].Cancer,2003,(3):568-574.doi:10.1002/cncr.11086.
  • 7Cohen JG,Kapp DS,Shin JY. Small cell carcinoma of the cervix:treatment and survival outcomes of 188 patients[J].American Journal of Obstetrics and Gynecology,2010.347.
  • 8Wang KL,Chang TC,Jung SM. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix:a Taiwan Residents Gynecologic Oncology Group study[J].European Journal of Cancer,2012.1484-1494.
  • 9Li JD,Zhuang Y,Li YF. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix:a single-centre study of 25 cases[J].Journal of Clinical Pathology,2011.1102-1107.
  • 10Delaloge S,Pautier P,Kerbrat P. Neuroendocrine small cell carcinoma of the uterine cervix:what disease? What treatment? Report of ten cases and a review of the literature[J].Clinical Oncology,2000.357-362.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部